Picardi, Marco, and Annamaria Vincenzi. 2020. “Is It Time to Increase the Liposomal Doxorubicin Dosage for Frontline Therapy in Young Adults and Adults With Classic Hodgkin Lymphoma? Comment On: ‘Is It Time to Reduce the Doxorubicin Dosage in Hodgkin Lymphoma therapy?’”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2026.301044.